Curis
CRIS
#10175
Rank
HK$0.10 B
Marketcap
HK$7.91
Share price
0.00%
Change (1 day)
-61.31%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.73. In 2024 the company made an earnings per share (EPS) of -HK$55.03 an increase over its 2023 EPS that were of -HK$70.68.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-48.06%
2024-HK$55.03-22.15%
2023-HK$70.68-26.17%
2022-HK$95.7322.3%
2021-HK$78.27-25.37%
2020-HK$104.89-30.93%
2019-HK$151.85-2.02%
2018-HK$154.98
2016-HK$352.23-10%
2015-HK$391.36138.1%
2014-HK$164.3740%
2013-HK$117.41-25%
2012-HK$156.5566.67%
2011-HK$93.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.65-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.25-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$18.63-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.46-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$87.98 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.04-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA